Manchester NHS Trust transitions MT-RNR1 to BAU

AI SummaryClose X

genedrive plc announced that Manchester University NHS Foundation Trust hospitals have transitioned its Genedrive® MT-RNR1 ID kit to Business as Usual clinical service for preventing antibiotic-induced hearing loss in neonates. This move follows participation in the PALOH-UK programme, where the test identified over 30 babies with the MT-RNR1 variant in Greater Manchester NICUs, enabling safer antibiotic prescriptions. The company is actively discussing similar transitions with other hospitals to ensure continued access to this preventive test across the UK, with funding for the PALOH-UK programme concluding by June 2026.

Disclaimer*

Companies

Genedrive (GDR)
UK 100

Latest directors dealings